Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Sperm DNA Test Diagnoses Idiopathic Infertility

By LabMedica International staff writers
Posted on 27 Nov 2012
A male fertility test has been utilized to discover the cause of unexplained infertility for many couples trying to have a baby. More...


Around 80% of couples who are diagnosed with unexplained or idiopathic infertility have a known cause called high sperm DNA damage and the test can help these couples understand better treatment options, which will keep them from wasting their money, time, and emotions.

Scientists at Queen's University Belfast (UK) studied over 500 couples, and utilized the male fertility test in the most recent round of trials conducted by the well-known male fertility experts at the university. Almost one third of couples had no obvious cause for infertility and these couples were given the diagnosis of “unexplained fertility.” These couples often invest a lot of time and money in fertility treatments like intrauterine insemination (IUI) which is unlikely to be successful. The study explained the cause of infertility for many of those couples.

The other significant finding revealed by the study is that it is the first to present evidence suggesting that the likelihood of conceiving after in vitro fertilization (IVF) is linked to the amount of damaged DNA a man's sperm contains. A small amount of damage such as less than 15% of sperm is considered normal. However, if the damage reaches more than 25% of sperm, the chances of having a baby are lowered, even if the couple is going through fertility treatment.

The male fertility test used in the study is called SpermComet (Lewis Fertility Testing Ltd, Belfast, UK). The SpermComet test is so called because it looks just like a comet in the skies. The head of the “comet” is undamaged DNA and the tail is damaged DNA. From the tail of the comet, the exact amount of damaged DNA in each individual sperm can be measured.

Sheena E.M. Lewis, PhD, a professor at Queen's University, said, "We have developed the SpermComet, which is a unique test for male infertility that measures damaged DNA in individual sperm providing all couples with specific information about the causes and extent of their infertility. This test can predict the success of infertility treatments and fast-track couples to the treatment most likely to succeed, leading to reduced waiting times and improved chances of success."

Related Links:

Queen's University Belfast
Lewis Fertility Testing Ltd.



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
DNA Extraction Kit
MagMAX DNA Multi-Sample Ultra 2.0 Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.